German hospitals seek budget loss cap to avoid DRG freefall
This article was originally published in Clinica
Executive Summary
With the convergence phase of the German diagnosis related groups (DRG) system of inpatient reimbursement costs set to shave millions of euros off hospital budgets over the next three years, the German hospitals association (DKG) is calling on the government to put a cap on hospital losses.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.